This work is supported by an NIGMS R35 to investigate the influence of the menstrual cycle on drug delivery and a NIEHS R21 to study the impact of tampon nanoplastics on gynecological health.Â
We would also like to thank HP Inc. for providing financial support through the HP Special Research Fund (VC2700).